APP Biosimilars Training Series Module 3 - Are Biosimilars as Effective as Originator Biologics?

Password

Forgot your password?

Select specialty

First name

Last name

Choose Password

Playback speed

10 seconds

By Crohn's & Colitis Foundation FEATURING Jamie Brogan, Angelina Collins

213 views

September 25, 2023

Click the link below for Training Series Module 4:
https://www.vumedi.com/video/app-biosimilar-training-module-4-insurer-mandated-switching-and-how-to-effectively-communicate-with/

This Crohn’s & Colitis Foundation ...
read more ↘ training series is designed to give advanced practice providers a better understanding of biosimilars as treatment options and how to discuss these options with patients. In this four-module series, APPs will learn how to introduce biosimilars to their patients, discuss initiation of a biologic/biosimilar, answer questions on efficacy compared to their originator drugs, and discuss an insurance mandated mandatory switch.

Additional Crohn's & Colitis Foundation educational resources:
https://crohnscolitisprofessional.org/clinical-topics/medical-therapy/

Upcoming Crohn's & Colitis Foundation events:
https://crohnscolitisprofessional.org/meetings/new/
↖ read less

Comments 0